Cargando…

Reply to: Assessment of administering antithrombosis in COVID-19 patients with acute hypoxemic respiratory failure

Detalles Bibliográficos
Autores principales:	Schiavone, Marco, Gasperetti, Alessio, Gobbi, Cecilia, Busana, Mattia, Forleo, Giovanni B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938788/ https://www.ncbi.nlm.nih.gov/pubmed/33705842 http://dx.doi.org/10.1016/j.ijcard.2021.03.009

Ejemplares similares

Assessment of administering antithrombosis in COVID-19 patients with acute hypoxemic respiratory failure
por: Wang, Ping, et al.
Publicado: (2021)

Altered Consciousness, Non-invasive Ventilation, and Hypoxemic Respiratory Failure: The Trident Question Unresolved - Reply
por: Kogo, Mariko, et al.
Publicado: (2019)

Non‐invasive hemodynamic profile of early COVID‐19 infection
por: Busana, Mattia, et al.
Publicado: (2020)

Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience
por: Schiavone, Marco, et al.
Publicado: (2021)

COVID-19: Non-Invasive Ventilation in Hypoxemic Acute Respiratory Failure
por: Rezaeitalab, Fariborz, et al.
Publicado: (2022)

Photodynamic and sonodynamic therapy of acute hypoxemic respiratory failure in patients with COVID-19
por: Kipshidze, Nicholas, et al.
Publicado: (2020)

Reply: Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19–associated Acute Hypoxemic Respiratory Failure?
por: Bellani, Giacomo, et al.
Publicado: (2021)

Acute heart failure in elderly patients: a review of invasive and non-invasive management
por: Tersalvi, Gregorio, et al.
Publicado: (2021)

Safety and Efficacy of Uninterrupted Oral Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation with Different Techniques
por: Schiavone, Marco, et al.
Publicado: (2023)

High-flow oxygen therapy in acute hypoxemic respiratory failure secondary to COVID-19 pneumonia()
por: Godoy, D.A., et al.
Publicado: (2021)

Natural Products for Antithrombosis
por: Chen, Cen, et al.
Publicado: (2015)

HACOR score to predict failure of non-invasive ventilation in patients with acute hypoxemic respiratory failure: When simplicity is best
por: Nair, Abhijit, et al.
Publicado: (2022)

Altered Consciousness, Non-invasive Ventilation and Hypoxemic Respiratory Failure: The Trident Question Unresolved
por: M. Esquinas, Antonio, et al.
Publicado: (2019)

Quis custodiet ipsos custodes: are we taking care of healthcare workers in the Italian COVID-19 outbreak?
por: Schiavone, M., et al.
Publicado: (2020)

Ventricular tachycardia storm management in a COVID-19 patient: a case report
por: Mitacchione, Gianfranco, et al.
Publicado: (2020)

The Complementary and Alternative Medicine for Antithrombosis
por: Yang, Feng-Qing, et al.
Publicado: (2015)

Reporting and representation of obesity in randomized controlled trials of noninvasive oxygenation strategies in hypoxemic respiratory failure
por: Gaulton, Timothy G., et al.
Publicado: (2022)

Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19
por: Shah, Akshay, et al.
Publicado: (2020)

Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19–associated Acute Hypoxemic Respiratory Failure?
por: Avdeev, Sergey N., et al.
Publicado: (2021)

ROX index to predict CPAP outcome in hypoxemic respiratory failure due to COVID-19
por: Colaianni-Alfonso, Nicolás, et al.
Publicado: (2022)

Histidine-rich glycoprotein: antithrombosis without bleeding
por: Schmaier, Alvin H.
Publicado: (2023)

The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure
por: Giraudo, C., et al.
Publicado: (2022)

Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties
por: Schiavone, Marco, et al.
Publicado: (2020)

Personalized noninvasive respiratory support for acute hypoxemic respiratory failure
por: Grieco, Domenico Luca, et al.
Publicado: (2023)

Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure
por: Thompson, Alison E., et al.
Publicado: (2020)

NIV-Helmet in Severe Hypoxemic Acute Respiratory Failure
por: Martins, Joana, et al.
Publicado: (2015)

Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure
por: Zucman, Noémie, et al.
Publicado: (2020)

The antithrombosis effect of dehydroandrographolide succinate: in vitro and in vivo studies
por: Yin, Bowen, et al.
Publicado: (2022)

An Unusual Suspect Causing Hypoxemic Respiratory Failure
por: Aqeel, Masooma, et al.
Publicado: (2017)

Hypoxemic Respiratory Failure: Evidence, Indications, and Exclusions
por: Abrams, Darryl, et al.
Publicado: (2015)

Reply to “The Difficulty in Administering Appropriate Antimicrobial Therapy for Stenotrophomonas maltophilia Bacteremia”
por: Ebara, Hirotaka, et al.
Publicado: (2017)

Early Clinical Experience in Using Helmet Continuous Positive Airway Pressure and High-Flow Nasal Cannula in Overweight and Obese Patients With Acute Hypoxemic Respiratory Failure From Coronavirus Disease 2019
por: Gaulton, Timothy G., et al.
Publicado: (2020)

Redefining the Prognostic Value of High-Sensitivity Troponin in COVID-19 Patients: The Importance of Concomitant Coronary Artery Disease
por: Schiavone, Marco, et al.
Publicado: (2020)

Diabetes and acute respiratory failure. Is the lung finally safe?
por: Gavelli, Francesco, et al.
Publicado: (2019)

Hypoxemic Respiratory Failure from Acute Respiratory Distress Syndrome Secondary to Leptospirosis
por: Fernando, Shannon M., et al.
Publicado: (2017)

Clinical Management of New-Onset Atrial Fibrillation in COVID-19 Patients Referred to a Tertiary Cardiac Arrhythmia Center after Hospital Discharge
por: Schiavone, Marco, et al.
Publicado: (2022)

Were Additional Treatments Affecting Pharmacokinetics Administered after Raltegravir Overdosing?: Authors' Reply
por: Hosoda, Tomohiro, et al.
Publicado: (2020)

Predictive factors associated with high‐flow nasal cannula success for COVID‐19‐related acute hypoxemic respiratory failure
por: Goury, Antoine, et al.
Publicado: (2021)

Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19
por: Schiavone, Marco, et al.
Publicado: (2022)

A plea for avoiding systematic intubation in severely hypoxemic patients with COVID-19-associated respiratory failure
por: Villarreal-Fernandez, Eduardo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fm22aq43vti6ov0gbofsdgjt7j